A20/TNFAIP3 inhibits NF-κB activation induced by the Kaposi’s sarcoma-associated herpesvirus vFLIP oncoprotein
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A20/TNFAIP3 inhibits NF-κB activation induced by the Kaposi’s sarcoma-associated herpesvirus vFLIP oncoprotein
Authors
Keywords
-
Journal
ONCOGENE
Volume 32, Issue 10, Pages 1223-1232
Publisher
Springer Nature
Online
2012-04-23
DOI
10.1038/onc.2012.145
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A20 (TNFAIP3) genetic alterations in EBV-associated AIDS-related lymphoma
- (2011) L. Giulino et al. BLOOD
- A20 Is Induced by Kaposi Sarcoma-associated Herpesvirus-encoded Viral FLICE Inhibitory Protein (vFLIP) K13 and Blocks K13-induced Nuclear Factor-κB in a Negative Feedback Manner
- (2011) Hittu Matta et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- NF-κB Essential Modulator (NEMO) Interaction with Linear and Lys-63 Ubiquitin Chains Contributes to NF-κB Activation
- (2011) Kamyar Hadian et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Kaposi sarcoma herpesvirus (KSHV) vFLIP oncoprotein induces B cell transdifferentiation and tumorigenesis in mice
- (2011) Gianna Ballon et al. JOURNAL OF CLINICAL INVESTIGATION
- NF- B Activation Stimulates Transcription and Replication of Retrovirus XMRV in Human B-Lineage and Prostate Carcinoma Cells
- (2011) S. Sakakibara et al. JOURNAL OF VIROLOGY
- The kinase IKKα inhibits activation of the transcription factor NF-κB by phosphorylating the regulatory molecule TAX1BP1
- (2011) Noula Shembade et al. NATURE IMMUNOLOGY
- Expression, biological activities and mechanisms of action of A20 (TNFAIP3)
- (2010) Lynn Verstrepen et al. BIOCHEMICAL PHARMACOLOGY
- Deubiquitinases in the regulation of NF-κB signaling
- (2010) Edward W Harhaj et al. CELL RESEARCH
- An Interleukin‐6–Related Systemic Inflammatory Syndrome in Patients Co‐Infected with Kaposi Sarcoma–Associated Herpesvirus and HIV but without Multicentric Castleman Disease
- (2010) Thomas S. Uldrick et al. CLINICAL INFECTIOUS DISEASES
- Inhibition of NF- B Signaling by A20 Through Disruption of Ubiquitin Enzyme Complexes
- (2010) N. Shembade et al. SCIENCE
- EphrinB reverse signaling contributes to endothelial and mural cell assembly into vascular structures
- (2009) O. Salvucci et al. BLOOD
- Integrated microarray and multiplex cytokine analyses of Kaposi's Sarcoma Associated Herpesvirus viral FLICE Inhibitory Protein K13 affected genes and cytokines in human blood vascular endothelial cells
- (2009) Vasu Punj et al. BMC Medical Genomics
- Specific Recognition of Linear Ubiquitin Chains by NEMO Is Important for NF-κB Activation
- (2009) Simin Rahighi et al. CELL
- The ubiquitin-editing enzyme A20 requires RNF11 to downregulate NF-κB signalling
- (2009) Noula Shembade et al. EMBO JOURNAL
- Crystal structure of the NEMO ubiquitin-binding domain in complex with Lys 63-linked di-ubiquitin
- (2009) Azusa Yoshikawa et al. FEBS LETTERS
- Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma
- (2009) Mara Compagno et al. NATURE
- Frequent inactivation of A20 in B-cell lymphomas
- (2009) Motohiro Kato et al. NATURE
- A20 is a negative regulator of BCL10- and CARMA3-mediated activation of NF- B
- (2008) R. Stilo et al. JOURNAL OF CELL SCIENCE
- Gene Regulation and Functional Alterations Induced by Kaposi's Sarcoma-Associated Herpesvirus-Encoded ORFK13/vFLIP in Endothelial Cells
- (2008) S. Sakakibara et al. JOURNAL OF VIROLOGY
- Viral Inhibitor of Apoptosis vFLIP/K13 Protects Endothelial Cells against Superoxide-Induced Cell Death
- (2008) M. Thurau et al. JOURNAL OF VIROLOGY
- Crystal Structure of a vFlip-IKKγ Complex: Insights into Viral Activation of the IKK Signalosome
- (2008) Claire Bagnéris et al. MOLECULAR CELL
- Ubiquitin binding mediates the NF-κB inhibitory potential of ABIN proteins
- (2008) S Wagner et al. ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started